PPM1D amplification and overexpression have been demonstrated in multiple human tumors, including neuroblastoma[15], pancreatic adenocarcinoma[16], medulloblastoma[17], breast cancer[18, 19] and ovarian clear cell carcinoma[20]. Here, PPM1D is linked to medulloblastoma.